Recent research focusing on Semaglutide at a dosage of 30mg is shedding new light on its potential benefits. Early findings suggest that this higher dosage may boost the drug's ability to manage blood glucose, potentially offering greater outcomes for individuals with diabetes. Further investigation is underway to fully evaluate the long-term impac